ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Veeva Expands Partnership With Novo Nordisk Through Vault CRM Adoption
(RTTNews) - Veeva Systems Inc. (VEEV), a cloud software company, on Wednesday said Novo Nordisk's International Operations business unit has committed to use Veeva Vault CRM, expanding the companies' existing partnership.
Announcement as on 07 January 2026

HC seeks Novo Nordisk's reply on Natco plea to revoke patent
The Delhi High Court has asked Novo Nordisk to explain why its patent for the diabetes and weight loss drug semaglutide should not be cancelled. Natco Pharma filed the petition. Novo Nordisk's patent expires in March. This has sparked patent disputes as ot
Announcement as on 06 January 2026

Take a pill! Novo Nordisk's Wegovy gets US' nod as daily pill for obesity treatment
Novo Nordisk's popular weight-loss drug Wegovy is now available as a pill in the US. The US Food and Drug Administration has approved the oral form. This offers a convenient daily option for adults struggling with obesity. The pill is expected to launch in
Announcement as on 23 December 2025

Healthify eyes more weight-loss drugmaker tie-ups after Novo Nordisk pact
Healthify, a prominent player in the Indian health-tech sector, is stepping up its collaborations with firms specializing in weight-loss medications. Following a strategic partnership with Novo Nordisk's division in India, the company is excited to roll ou
Announcement as on 05 December 2025

Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment
The joint studies showed some improvement in a few biological measures of the disease, but most of the changes were small and not enough to make a difference in delaying cognitive decline.
Announcement as on 04 December 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 36.31
  • 12Day Average: 36.67
  • 20Day Average: 37.48
  • 50Day Average: 44.43
  • 100Day Average: 47.78
  • 150Day Average: 50.32
  • 200Day Average: 53.51

NVO Indicators & signals

Indicator MACD (12,26,9)

36.9, 38.84, -2.38
Indicator MACD is in negative zone

Indicator ADX (14)

24.64, 17.69, 29.25
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Apr 2026 36.98 35.63 to 36.98 1.37% 0.69 times
01 Wed Apr 2026 36.48 35.78 to 37.44 -0.73% 1.14 times
31 Tue Mar 2026 36.75 35.32 to 36.75 4.05% 1.13 times
30 Mon Mar 2026 35.32 35.06 to 35.65 -1.97% 0.82 times
27 Fri Mar 2026 36.03 35.89 to 37.20 -0.96% 0.7 times
26 Thu Mar 2026 36.38 35.51 to 37.44 0.14% 0.99 times
25 Wed Mar 2026 36.33 36.23 to 37.39 -1.52% 0.98 times
24 Tue Mar 2026 36.89 36.55 to 37.20 0.19% 0.96 times
23 Mon Mar 2026 36.82 36.48 to 37.21 0.77% 0.9 times
20 Fri Mar 2026 36.54 35.86 to 37.33 -1.43% 1.32 times
19 Thu Mar 2026 37.07 36.17 to 37.47 -3.56% 1.05 times
17 Tue Mar 2026 38.44 38.30 to 39.27 -0.36% 0.6 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top